Can effect of finasteride on prostate-specific antigen be used to decrease repeat prostate biopsy?

Basit Öğe Kaydı
dc.authoridGORUR, Sadik/0000-0002-3458-5428
dc.contributor.authorGorur, Sadik
dc.contributor.authorBozlu, Murat
dc.date.accessioned2024-09-18T21:07:50Z
dc.date.available2024-09-18T21:07:50Z
dc.date.issued2006
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractMany patients have had persistently elevated PSA levels and have undergoing multiple negative prostate biopsies. No consensus has been reached on the treatment of patients who continue to have elevated PSA levels despite negative biopsy findings. In the current study, the authors examined the correlation among finasteride treatment, PSA and PSAD to determine patients who could be excluded from repeat prostate biopsy. They found that patients without prostate cancer have a greater decrease in PSAD when taking finasteride for 6 months than those with prostate cancer.en_US
dc.identifier.endpage27en_US
dc.identifier.issn2147-2270
dc.identifier.issue4en_US
dc.identifier.startpage26en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/13984
dc.identifier.volume5en_US
dc.identifier.wosWOS:000219333300008en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofUroonkoloji Bulteni-Bulletin of Urooncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleCan effect of finasteride on prostate-specific antigen be used to decrease repeat prostate biopsy?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu